Patents by Inventor Perry KIRKHAM

Perry KIRKHAM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Canine PD-L1 antibody, antigen binding fragments thereof, and methods of use thereof
    Patent number: 12753234
    Abstract: Caninized antibodies and antigen binding fragments thereof are provided that bind programmed death ligand 1 in a canine subject. Methods of treating cancer in a canine subject using the caninized antibodies and/or antigen binding fragments are also provided, as are methods for predicting and modeling anti-cancer activity of a test compound in a subject.
    Type: Grant
    Filed: May 13, 2025
    Date of Patent: October 6, 2026
    Assignee: PURDUE RESEARCH FOUNDATION
    Inventors: Deborah Knapp, Deepika Dhawan, Seung-Oe Lim, Perry Kirkham
  • CANINE PD-L1 ANTIBODY, ANTIGEN BINDING FRAGMENTS THEREOF, AND METHODS OF USE THEREOF
    Publication number: 20260193355
    Abstract: Caninized antibodies and antigen binding fragments thereof are provided that bind programmed death ligand 1 in a canine subject. Methods of treating cancer in a canine subject using the caninized antibodies and/or antigen binding fragments are also provided, as are methods for predicting and modeling anti-cancer activity of a test compound in a subject.
    Type: Application
    Filed: November 14, 2023
    Publication date: July 9, 2026
    Inventors: Deborah KNAPP, Deepika DHAWAN, Seung-Oe LIM, Perry KIRKHAM
  • CANINE PD-L1 ANTIBODY, ANTIGEN BINDING FRAGMENTS THEREOF, AND METHODS OF USE THEREOF
    Publication number: 20250277039
    Abstract: Caninized antibodies and antigen binding fragments thereof are provided that bind programmed death ligand 1 in a canine subject. Methods of treating cancer in a canine subject using the caninized antibodies and/or antigen binding fragments are also provided, as are methods for predicting and modeling anti-cancer activity of a test compound in a subject.
    Type: Application
    Filed: May 13, 2025
    Publication date: September 4, 2025
    Inventors: Deborah KNAPP, Deepika DHAWAN, Seung-Oe LIM, Perry KIRKHAM